Stock Information
NewAmsterdam Pharma Company NV (NAMS)
Ticker Symbol: NAMS
Exchange: NASDAQ
Sector: Biotechnology
Market Cap: $2,969.36 mil
Piotroski score: 4
PE Ratio: N/A
EPS (TTM): -2.15
Revenue (TTM): $0.06 M
Dividend Yield: N/A
ROE: -38.33%
Latest News
-
RBC Capital Maintains Outperform on NewAmsterdam Pharma Co, Lowers Price Target to $42
Mon, Oct 5, 2026 9:32 AM
Key Financials
Financial data not available